Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03326193
Title Phase 2, A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.